Global and Japan Quetiapine Fumarate Market Insights, Forecast to 2027

Publisher Name :
Date: 10-Sep-2021
No. of pages: 146
Inquire Before Buying

Quetiapine Fumarate is an atypical antipsychotic drug used to treat psychiatric disorders such as schizophrenia, bipolar disorder and depression. It may be used alone or in combination with other psychiatric medications. It is taken orally, and is available only by prescription, under the supervision of a medical practitioner.

Europe is the largest Quetiapine Fumarate market with about 92% market share. China is follower, accounting for about 2% market share.

The key players are AstraZeneca, Intas, TAPI, Accord, Hexal, Dr.Reddy's, Lupin, Sun Pharmaceutical, Hunan Dongting Pharm, SuZhou NO.4 Phamaceutical Factory, Fuan Pharmaceutical, Zhejiang Supor Pharmaceuticals, Zhejiang Huahai Pharmaceutical etc. Top 3 companies occupied about 74% market share.

Market Analysis and Insights: Global and Japan Quetiapine Fumarate Market

This report focuses on global and Japan Quetiapine Fumarate market.

In 2020, the global Quetiapine Fumarate market size was US$ 163.3 million and it is expected to reach US$ 139.8 million by the end of 2027, with a CAGR of -2.2% during 2021-2027. In Japan the Quetiapine Fumarate market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Quetiapine Fumarate Scope and Market Size

Quetiapine Fumarate market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Quetiapine Fumarate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For Japan market, this report focuses on the Quetiapine Fumarate market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in Japan.

Segment by Type

- Immediate Release Tablets

- Extended Release Tablets

Segment by Application

- Adult

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- AstraZeneca

- Intas

- TAPI

- Accord

- Hexal

- Dr.Reddy's

- Lupin

- Sun Pharmaceutical

- Hunan Dongting Pharm

- SuZhou NO.4 Phamaceutical Factory

- Fuan Pharmaceutical

- Zhejiang Supor Pharmaceuticals

- Zhejiang Huahai Pharmaceutical

Global and Japan Quetiapine Fumarate Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Quetiapine Fumarate Product Introduction
1.2 Market by Type
1.2.1 Global Quetiapine Fumarate Market Size Growth Rate by Type
1.2.2 Immediate Release Tablets
1.2.3 Extended Release Tablets
1.3 Market by Application
1.3.1 Global Quetiapine Fumarate Market Size Growth Rate by Application
1.3.2 Adult
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Quetiapine Fumarate Market Size, Estimates and Forecasts
2.1.1 Global Quetiapine Fumarate Revenue 2016-2027
2.1.2 Global Quetiapine Fumarate Sales 2016-2027
2.2 Global Quetiapine Fumarate, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Quetiapine Fumarate Historical Market Size by Region (2016-2021)
2.3.1 Global Quetiapine Fumarate Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Quetiapine Fumarate Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Quetiapine Fumarate Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Quetiapine Fumarate Sales Forecast by Region (2022-2027)
2.4.2 Global Quetiapine Fumarate Revenue Forecast by Region (2022-2027)
3 Global Quetiapine Fumarate Competitor Landscape by Players
3.1 Global Top Quetiapine Fumarate Manufacturers by Sales
3.1.1 Global Quetiapine Fumarate Sales by Manufacturer (2016-2021)
3.1.2 Global Quetiapine Fumarate Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Quetiapine Fumarate Manufacturers by Revenue
3.2.1 Key Quetiapine Fumarate Manufacturers Covered: Ranking by Revenue
3.2.2 Global Quetiapine Fumarate Revenue by Manufacturers (2016-2021)
3.2.3 Global Quetiapine Fumarate Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Quetiapine Fumarate Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Quetiapine Fumarate Revenue in 2020
3.2.6 Global Quetiapine Fumarate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Quetiapine Fumarate Price by Manufacturers
3.4 Global Quetiapine Fumarate Manufacturing Base Distribution, Product Types
3.4.1 Quetiapine Fumarate Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Quetiapine Fumarate Product Type
3.4.3 Date of International Manufacturers Enter into Quetiapine Fumarate Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Quetiapine Fumarate Market Size by Type (2016-2021)
4.1.1 Global Quetiapine Fumarate Sales by Type (2016-2021)
4.1.2 Global Quetiapine Fumarate Revenue by Type (2016-2021)
4.1.3 Quetiapine Fumarate Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Quetiapine Fumarate Market Size Forecast by Type (2022-2027)
4.2.1 Global Quetiapine Fumarate Sales Forecast by Type (2022-2027)
4.2.2 Global Quetiapine Fumarate Revenue Forecast by Type (2022-2027)
4.2.3 Quetiapine Fumarate Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Quetiapine Fumarate Market Size by Application (2016-2021)
5.1.1 Global Quetiapine Fumarate Sales by Application (2016-2021)
5.1.2 Global Quetiapine Fumarate Revenue by Application (2016-2021)
5.1.3 Quetiapine Fumarate Price by Application (2016-2021)
5.2 Quetiapine Fumarate Market Size Forecast by Application (2022-2027)
5.2.1 Global Quetiapine Fumarate Sales Forecast by Application (2022-2027)
5.2.2 Global Quetiapine Fumarate Revenue Forecast by Application (2022-2027)
5.2.3 Global Quetiapine Fumarate Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Quetiapine Fumarate Market Size YoY Growth 2016-2027
6.1.1 Japan Quetiapine Fumarate Sales YoY Growth 2016-2027
6.1.2 Japan Quetiapine Fumarate Revenue YoY Growth 2016-2027
6.1.3 Japan Quetiapine Fumarate Market Share in Global Market 2016-2027
6.2 Japan Quetiapine Fumarate Market Size by Players (International and Local Players)
6.2.1 Japan Top Quetiapine Fumarate Players by Sales (2016-2021)
6.2.2 Japan Top Quetiapine Fumarate Players by Revenue (2016-2021)
6.3 Japan Quetiapine Fumarate Historic Market Review by Type (2016-2021)
6.3.1 Japan Quetiapine Fumarate Sales Market Share by Type (2016-2021)
6.3.2 Japan Quetiapine Fumarate Revenue Market Share by Type (2016-2021)
6.3.3 Japan Quetiapine Fumarate Price by Type (2016-2021)
6.4 Japan Quetiapine Fumarate Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Quetiapine Fumarate Sales Forecast by Type (2022-2027)
6.4.2 Japan Quetiapine Fumarate Revenue Forecast by Type (2022-2027)
6.4.3 Japan Quetiapine Fumarate Price Forecast by Type (2022-2027)
6.5 Japan Quetiapine Fumarate Historic Market Review by Application (2016-2021)
6.5.1 Japan Quetiapine Fumarate Sales Market Share by Application (2016-2021)
6.5.2 Japan Quetiapine Fumarate Revenue Market Share by Application (2016-2021)
6.5.3 Japan Quetiapine Fumarate Price by Application (2016-2021)
6.6 Japan Quetiapine Fumarate Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Quetiapine Fumarate Sales Forecast by Application (2022-2027)
6.6.2 Japan Quetiapine Fumarate Revenue Forecast by Application (2022-2027)
6.6.3 Japan Quetiapine Fumarate Price Forecast by Application (2022-2027)
7 North America
7.1 North America Quetiapine Fumarate Market Size YoY Growth 2016-2027
7.2 North America Quetiapine Fumarate Market Facts & Figures by Country
7.2.1 North America Quetiapine Fumarate Sales by Country (2016-2021)
7.2.2 North America Quetiapine Fumarate Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Quetiapine Fumarate Market Size YoY Growth 2016-2027
8.2 Asia Pacific Quetiapine Fumarate Market Facts & Figures by Region
8.2.1 Asia Pacific Quetiapine Fumarate Sales by Region (2016-2021)
8.2.2 Asia Pacific Quetiapine Fumarate Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Quetiapine Fumarate Market Size YoY Growth 2016-2027
9.2 Europe Quetiapine Fumarate Market Facts & Figures by Country
9.2.1 Europe Quetiapine Fumarate Sales by Country (2016-2021)
9.2.2 Europe Quetiapine Fumarate Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Quetiapine Fumarate Market Size YoY Growth 2016-2027
10.2 Latin America Quetiapine Fumarate Market Facts & Figures by Country
10.2.1 Latin America Quetiapine Fumarate Sales by Country (2016-2021)
10.2.2 Latin America Quetiapine Fumarate Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Quetiapine Fumarate Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Quetiapine Fumarate Market Facts & Figures by Country
11.2.1 Middle East and Africa Quetiapine Fumarate Sales by Country (2016-2021)
11.2.2 Middle East and Africa Quetiapine Fumarate Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 AstraZeneca
12.1.1 AstraZeneca Corporation Information
12.1.2 AstraZeneca Description and Business Overview
12.1.3 AstraZeneca Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)
12.1.4 AstraZeneca Quetiapine Fumarate Products Offered
12.1.5 AstraZeneca Recent Development
12.2 Intas
12.2.1 Intas Corporation Information
12.2.2 Intas Description and Business Overview
12.2.3 Intas Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Intas Quetiapine Fumarate Products Offered
12.2.5 Intas Recent Development
12.3 TAPI
12.3.1 TAPI Corporation Information
12.3.2 TAPI Description and Business Overview
12.3.3 TAPI Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)
12.3.4 TAPI Quetiapine Fumarate Products Offered
12.3.5 TAPI Recent Development
12.4 Accord
12.4.1 Accord Corporation Information
12.4.2 Accord Description and Business Overview
12.4.3 Accord Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Accord Quetiapine Fumarate Products Offered
12.4.5 Accord Recent Development
12.5 Hexal
12.5.1 Hexal Corporation Information
12.5.2 Hexal Description and Business Overview
12.5.3 Hexal Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Hexal Quetiapine Fumarate Products Offered
12.5.5 Hexal Recent Development
12.6 Dr.Reddy's
12.6.1 Dr.Reddy's Corporation Information
12.6.2 Dr.Reddy's Description and Business Overview
12.6.3 Dr.Reddy's Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Dr.Reddy's Quetiapine Fumarate Products Offered
12.6.5 Dr.Reddy's Recent Development
12.7 Lupin
12.7.1 Lupin Corporation Information
12.7.2 Lupin Description and Business Overview
12.7.3 Lupin Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Lupin Quetiapine Fumarate Products Offered
12.7.5 Lupin Recent Development
12.8 Sun Pharmaceutical
12.8.1 Sun Pharmaceutical Corporation Information
12.8.2 Sun Pharmaceutical Description and Business Overview
12.8.3 Sun Pharmaceutical Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Sun Pharmaceutical Quetiapine Fumarate Products Offered
12.8.5 Sun Pharmaceutical Recent Development
12.9 Hunan Dongting Pharm
12.9.1 Hunan Dongting Pharm Corporation Information
12.9.2 Hunan Dongting Pharm Description and Business Overview
12.9.3 Hunan Dongting Pharm Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Hunan Dongting Pharm Quetiapine Fumarate Products Offered
12.9.5 Hunan Dongting Pharm Recent Development
12.10 SuZhou NO.4 Phamaceutical Factory
12.10.1 SuZhou NO.4 Phamaceutical Factory Corporation Information
12.10.2 SuZhou NO.4 Phamaceutical Factory Description and Business Overview
12.10.3 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)
12.10.4 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Products Offered
12.10.5 SuZhou NO.4 Phamaceutical Factory Recent Development
12.11 AstraZeneca
12.11.1 AstraZeneca Corporation Information
12.11.2 AstraZeneca Description and Business Overview
12.11.3 AstraZeneca Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)
12.11.4 AstraZeneca Quetiapine Fumarate Products Offered
12.11.5 AstraZeneca Recent Development
12.12 Zhejiang Supor Pharmaceuticals
12.12.1 Zhejiang Supor Pharmaceuticals Corporation Information
12.12.2 Zhejiang Supor Pharmaceuticals Description and Business Overview
12.12.3 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Zhejiang Supor Pharmaceuticals Products Offered
12.12.5 Zhejiang Supor Pharmaceuticals Recent Development
12.13 Zhejiang Huahai Pharmaceutical
12.13.1 Zhejiang Huahai Pharmaceutical Corporation Information
12.13.2 Zhejiang Huahai Pharmaceutical Description and Business Overview
12.13.3 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Zhejiang Huahai Pharmaceutical Products Offered
12.13.5 Zhejiang Huahai Pharmaceutical Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Quetiapine Fumarate Industry Trends
13.2 Quetiapine Fumarate Market Drivers
13.3 Quetiapine Fumarate Market Challenges
13.4 Quetiapine Fumarate Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Quetiapine Fumarate Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Quetiapine Fumarate Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Immediate Release Tablets
Table 3. Major Manufacturers of Extended Release Tablets
Table 4. Global Quetiapine Fumarate Market Size Growth Rate by Application (2021-2027) & (MT)
Table 5. Global Quetiapine Fumarate Market Size by Region (MT) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Quetiapine Fumarate Sales by Regions (2016-2021) & (MT)
Table 7. Global Quetiapine Fumarate Sales Market Share by Regions (2016-2021)
Table 8. Global Quetiapine Fumarate Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Quetiapine Fumarate Sales Forecast by Region (2022-2027) & (MT)
Table 10. Global Quetiapine Fumarate Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Quetiapine Fumarate Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Quetiapine Fumarate Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Quetiapine Fumarate Sales by Manufacturers (2016-2021) (MT)
Table 14. Global Quetiapine Fumarate Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Quetiapine Fumarate Manufacturers by Revenue (US$ Million) in 2020
Table 16. Quetiapine Fumarate Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Quetiapine Fumarate Revenue Share by Manufacturers (2016-2021)
Table 18. Global Quetiapine Fumarate Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Quetiapine Fumarate by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Quetiapine Fumarate as of 2020)
Table 20. Key Manufacturers Quetiapine Fumarate Price (2016-2021) (USD/Kg)
Table 21. Quetiapine Fumarate Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Quetiapine Fumarate Product Type
Table 23. Date of International Manufacturers Enter into Quetiapine Fumarate Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Quetiapine Fumarate Sales by Type (2016-2021) (MT)
Table 26. Global Quetiapine Fumarate Sales Share by Type (2016-2021)
Table 27. Global Quetiapine Fumarate Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Quetiapine Fumarate Revenue Share by Type (2016-2021)
Table 29. Quetiapine Fumarate Average Selling Price (ASP) by Type (2016-2021) & (USD/Kg)
Table 30. Global Quetiapine Fumarate Sales Forecast by Type (2022-2027) & (MT)
Table 31. Global Quetiapine Fumarate Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Quetiapine Fumarate Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Quetiapine Fumarate Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Quetiapine Fumarate Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Kg)
Table 35. Global Quetiapine Fumarate Sales by Application (2016-2021) (MT)
Table 36. Global Quetiapine Fumarate Sales Share by Application (2016-2021)
Table 37. Global Quetiapine Fumarate Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Quetiapine Fumarate Revenue Share by Application (2016-2021)
Table 39. Quetiapine Fumarate Average Selling Price (ASP) by Application (2016-2021) & (USD/Kg)
Table 40. Global Quetiapine Fumarate Sales Forecast by Application (2022-2027) & (MT)
Table 41. Global Quetiapine Fumarate Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Quetiapine Fumarate Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Quetiapine Fumarate Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Quetiapine Fumarate Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Kg)
Table 45. Japan Quetiapine Fumarate Sales (MT) of Key Companies (2016-2021)
Table 46. Japan Quetiapine Fumarate Sales Share by Company (2016-2021)
Table 47. Japan Quetiapine Fumarate Revenue (US$ Million) by Company (2016-2021)
Table 48. Japan Quetiapine Fumarate Revenue Share by Company (2016-2021)
Table 49. Japan Quetiapine Fumarate Sales (MT) by Type (2016-2021)
Table 50. Japan Quetiapine Fumarate Sales Share by Type (2016-2021)
Table 51. Japan Quetiapine Fumarate Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. Japan Quetiapine Fumarate Price (USD/Kg) by Type (2016-2021)
Table 53. Japan Quetiapine Fumarate Sales (MT) by Type (2022-2027)
Table 54. Japan Quetiapine Fumarate Sales Share by Type (2022-2027)
Table 55. Japan Quetiapine Fumarate Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. Japan Quetiapine Fumarate Revenue Share by Type (2022-2027)
Table 57. Japan Quetiapine Fumarate Price (USD/Kg) by Type (2022-2027)
Table 58. Japan Quetiapine Fumarate Sales (MT) by Application (2016-2021)
Table 59. Japan Quetiapine Fumarate Sales Share by Application (2016-2021)
Table 60. Japan Quetiapine Fumarate Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. Japan Quetiapine Fumarate Price (USD/Kg) by Application (2016-2021)
Table 62. Japan Quetiapine Fumarate Sales (MT) by Application (2022-2027)
Table 63. Japan Quetiapine Fumarate Sales Share by Application (2022-2027)
Table 64. Japan Quetiapine Fumarate Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. Japan Quetiapine Fumarate Revenue Share by Application (2022-2027)
Table 66. Japan Quetiapine Fumarate Price (USD/Kg) by Application (2022-2027)
Table 67. North America Quetiapine Fumarate Sales by Country (2016-2021) & (MT)
Table 68. North America Quetiapine Fumarate Sales Market Share by Country (2016-2021)
Table 69. North America Quetiapine Fumarate Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Quetiapine Fumarate Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Quetiapine Fumarate Sales by Region (2016-2021) & (MT)
Table 72. Asia Pacific Quetiapine Fumarate Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Quetiapine Fumarate Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Quetiapine Fumarate Revenue Market Share by Region (2016-2021)
Table 75. Europe Quetiapine Fumarate Sales by Country (2016-2021) & (MT)
Table 76. Europe Quetiapine Fumarate Sales Market Share by Country (2016-2021)
Table 77. Europe Quetiapine Fumarate Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Quetiapine Fumarate Revenue Market Share by Country (2016-2021)
Table 79. Latin America Quetiapine Fumarate Sales by Country (2016-2021) & (MT)
Table 80. Latin America Quetiapine Fumarate Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Quetiapine Fumarate Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Quetiapine Fumarate Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Quetiapine Fumarate Sales by Country (2016-2021) & (MT)
Table 84. Middle East and Africa Quetiapine Fumarate Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Quetiapine Fumarate Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Quetiapine Fumarate Revenue Market Share by Country (2016-2021)
Table 87. AstraZeneca Corporation Information
Table 88. AstraZeneca Description and Business Overview
Table 89. AstraZeneca Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 90. AstraZeneca Quetiapine Fumarate Product
Table 91. AstraZeneca Recent Development
Table 92. Intas Corporation Information
Table 93. Intas Description and Business Overview
Table 94. Intas Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 95. Intas Product
Table 96. Intas Recent Development
Table 97. TAPI Corporation Information
Table 98. TAPI Description and Business Overview
Table 99. TAPI Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 100. TAPI Product
Table 101. TAPI Recent Development
Table 102. Accord Corporation Information
Table 103. Accord Description and Business Overview
Table 104. Accord Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 105. Accord Product
Table 106. Accord Recent Development
Table 107. Hexal Corporation Information
Table 108. Hexal Description and Business Overview
Table 109. Hexal Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 110. Hexal Product
Table 111. Hexal Recent Development
Table 112. Dr.Reddy's Corporation Information
Table 113. Dr.Reddy's Description and Business Overview
Table 114. Dr.Reddy's Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 115. Dr.Reddy's Product
Table 116. Dr.Reddy's Recent Development
Table 117. Lupin Corporation Information
Table 118. Lupin Description and Business Overview
Table 119. Lupin Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 120. Lupin Product
Table 121. Lupin Recent Development
Table 122. Sun Pharmaceutical Corporation Information
Table 123. Sun Pharmaceutical Description and Business Overview
Table 124. Sun Pharmaceutical Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 125. Sun Pharmaceutical Product
Table 126. Sun Pharmaceutical Recent Development
Table 127. Hunan Dongting Pharm Corporation Information
Table 128. Hunan Dongting Pharm Description and Business Overview
Table 129. Hunan Dongting Pharm Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 130. Hunan Dongting Pharm Product
Table 131. Hunan Dongting Pharm Recent Development
Table 132. SuZhou NO.4 Phamaceutical Factory Corporation Information
Table 133. SuZhou NO.4 Phamaceutical Factory Description and Business Overview
Table 134. SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 135. SuZhou NO.4 Phamaceutical Factory Product
Table 136. SuZhou NO.4 Phamaceutical Factory Recent Development
Table 137. Fuan Pharmaceutical Corporation Information
Table 138. Fuan Pharmaceutical Description and Business Overview
Table 139. Fuan Pharmaceutical Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 140. Fuan Pharmaceutical Product
Table 141. Fuan Pharmaceutical Recent Development
Table 142. Zhejiang Supor Pharmaceuticals Corporation Information
Table 143. Zhejiang Supor Pharmaceuticals Description and Business Overview
Table 144. Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 145. Zhejiang Supor Pharmaceuticals Product
Table 146. Zhejiang Supor Pharmaceuticals Recent Development
Table 147. Zhejiang Huahai Pharmaceutical Corporation Information
Table 148. Zhejiang Huahai Pharmaceutical Description and Business Overview
Table 149. Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 150. Zhejiang Huahai Pharmaceutical Product
Table 151. Zhejiang Huahai Pharmaceutical Recent Development
Table 152. Quetiapine Fumarate Market Trends
Table 153. Quetiapine Fumarate Market Drivers
Table 154. Quetiapine Fumarate Market Challenges
Table 155. Quetiapine Fumarate Market Restraints
Table 156. Quetiapine Fumarate Customers List
Table 157. Quetiapine Fumarate Distributors List
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Quetiapine Fumarate Product Picture
Figure 2. Global Quetiapine Fumarate Sales Market Share by Type in 2020 & 2027
Figure 3. Immediate Release Tablets Product Picture
Figure 4. Extended Release Tablets Product Picture
Figure 5. Global Quetiapine Fumarate Sales Market Share by Application in 2020 & 2027
Figure 6. Adult
Figure 7. Others
Figure 8. Quetiapine Fumarate Report Years Considered
Figure 9. Global Quetiapine Fumarate Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Quetiapine Fumarate Market Size 2016-2027 (US$ Million)
Figure 11. Global Quetiapine Fumarate Sales 2016-2027 (MT)
Figure 12. Global Quetiapine Fumarate Market Size Market Share by Region: 2021 Versus 2027
Figure 13. Global Quetiapine Fumarate Sales Market Share by Region (2016-2021)
Figure 14. Global Quetiapine Fumarate Sales Market Share by Region in 2020
Figure 15. Global Quetiapine Fumarate Revenue Market Share by Region (2016-2021)
Figure 16. Global Quetiapine Fumarate Revenue Market Share by Region in 2020
Figure 17. Global Quetiapine Fumarate Sales Share by Manufacturer in 2020
Figure 18. The Top 10 and 5 Players Market Share by Quetiapine Fumarate Revenue in 2020
Figure 19. Quetiapine Fumarate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 20. Global Quetiapine Fumarate Sales Market Share by Type (2016-2021)
Figure 21. Global Quetiapine Fumarate Sales Market Share by Type in 2020
Figure 22. Global Quetiapine Fumarate Revenue Market Share by Type (2016-2021)
Figure 23. Global Quetiapine Fumarate Revenue Market Share by Type in 2020
Figure 24. Global Quetiapine Fumarate Sales Market Share by Application (2016-2021)
Figure 25. Global Quetiapine Fumarate Sales Market Share by Application in 2020
Figure 26. Global Quetiapine Fumarate Revenue Market Share by Application (2016-2021)
Figure 27. Global Quetiapine Fumarate Revenue Market Share by Application in 2020
Figure 28. Japan Quetiapine Fumarate Sales Growth Rate 2016-2027 (MT)
Figure 29. Japan Quetiapine Fumarate Revenue Growth Rate 2016-2027 (US$ Million)
Figure 30. Japan Quetiapine Fumarate Market Share in Global Market 2016-2027
Figure 31. Japan 5 and 10 Largest Quetiapine Fumarate Players Market Share by Revenue in Quetiapine Fumarate in 2020
Figure 32. Japan Quetiapine Fumarate Revenue Share by Type (2016-2021)
Figure 33. Japan Quetiapine Fumarate Revenue Growth Rate by Type in 2016 & 2020
Figure 34. Japan Quetiapine Fumarate Revenue Share by Application (2016-2021)
Figure 35. Japan Quetiapine Fumarate Revenue Growth Rate by Application in 2016 & 2020
Figure 36. North America Quetiapine Fumarate Sales Growth Rate 2016-2021 (MT)
Figure 37. North America Quetiapine Fumarate Revenue Growth Rate 2016-2021 (US$ Million)
Figure 38. North America Quetiapine Fumarate Sales Market Share by Country in 2020
Figure 39. North America Quetiapine Fumarate Revenue Market Share by Country in 2020
Figure 40. U.S. Quetiapine Fumarate Sales Growth Rate (2016-2021) (MT)
Figure 41. U.S. Quetiapine Fumarate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Canada Quetiapine Fumarate Sales Growth Rate (2016-2021) (MT)
Figure 43. Canada Quetiapine Fumarate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Europe Quetiapine Fumarate Sales Growth Rate 2016-2021 (MT)
Figure 45. Europe Quetiapine Fumarate Revenue Growth Rate 2016-2021 (US$ Million)
Figure 46. Europe Quetiapine Fumarate Sales Market Share by Country in 2020
Figure 47. Europe Quetiapine Fumarate Revenue Market Share by Country in 2020
Figure 48. Germany Quetiapine Fumarate Sales Growth Rate (2016-2021) (MT)
Figure 49. Germany Quetiapine Fumarate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. France Quetiapine Fumarate Sales Growth Rate (2016-2021) (MT)
Figure 51. France Quetiapine Fumarate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. U.K. Quetiapine Fumarate Sales Growth Rate (2016-2021) (MT)
Figure 53. U.K. Quetiapine Fumarate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. Italy Quetiapine Fumarate Sales Growth Rate (2016-2021) (MT)
Figure 55. Italy Quetiapine Fumarate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Russia Quetiapine Fumarate Sales Growth Rate (2016-2021) (MT)
Figure 57. Russia Quetiapine Fumarate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Asia Pacific Quetiapine Fumarate Sales Growth Rate 2016-2021 (MT)
Figure 59. Asia Pacific Quetiapine Fumarate Revenue Growth Rate 2016-2021 (US$ Million)
Figure 60. Asia Pacific Quetiapine Fumarate Sales Market Share by Region in 2020
Figure 61. Asia Pacific Quetiapine Fumarate Revenue Market Share by Region in 2020
Figure 62. China Quetiapine Fumarate Sales Growth Rate (2016-2021) (MT)
Figure 63. China Quetiapine Fumarate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 64. Japan Quetiapine Fumarate Sales Growth Rate (2016-2021) (MT)
Figure 65. Japan Quetiapine Fumarate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. South Korea Quetiapine Fumarate Sales Growth Rate (2016-2021) (MT)
Figure 67. South Korea Quetiapine Fumarate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. India Quetiapine Fumarate Sales Growth Rate (2016-2021) (MT)
Figure 69. India Quetiapine Fumarate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. Australia Quetiapine Fumarate Sales Growth Rate (2016-2021) (MT)
Figure 71. Australia Quetiapine Fumarate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Taiwan Quetiapine Fumarate Sales Growth Rate (2016-2021) (MT)
Figure 73. Taiwan Quetiapine Fumarate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Indonesia Quetiapine Fumarate Sales Growth Rate (2016-2021) (MT)
Figure 75. Indonesia Quetiapine Fumarate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Thailand Quetiapine Fumarate Sales Growth Rate (2016-2021) (MT)
Figure 77. Thailand Quetiapine Fumarate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Malaysia Quetiapine Fumarate Sales Growth Rate (2016-2021) (MT)
Figure 79. Malaysia Quetiapine Fumarate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Philippines Quetiapine Fumarate Sales Growth Rate (2016-2021) (MT)
Figure 81. Philippines Quetiapine Fumarate Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Vietnam Quetiapine Fumarate Sales Growth Rate (2016-2021) (MT)
Figure 83. Vietnam Quetiapine Fumara
  • Global Divalproex Sodium Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 81
    Divalproex Sodium is used to treat certain types of seizures (epilepsy). This medicine is an anticonvulsant that works in The brain tissue to stop seizures. Divalproex Sodium is also used to treat The manic phase of bipolar disorder (manic-depressive illness), and helps prevent migraine headaches. This medicine is available only with your doctor's prescription. The global Divalproex Sodium market was valued at US$ 2188.5 million in 2023 and is anticipated to reach US$ 33......
  • Global Divalproex Sodium Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Divalproex Sodium market size was valued at US$ 2140.9 million in 2023. With growing demand in downstream market, the Divalproex Sodium is forecast to a readjusted size of US$ 3312 million by 2030 with a CAGR of 6.4% during review period. The research report highlights the growth potential of the global Divalproex Sodium market. Divalproex Sodium are expected to show stable growth in the future market. However, product differ......
  • Global Quetiapine Fumarate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global Quetiapine Fumarate market size was valued at US$ 156.2 million in 2023. With growing demand in downstream market, the Quetiapine Fumarate is forecast to a readjusted size of US$ 132.9 million by 2030 with a CAGR of -2.3% during review period. The research report highlights the growth potential of the global Quetiapine Fumarate market. Quetiapine Fumarate are expected to show stable growth in the future market. However, produ......
  • Global Clozapine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114
    According to our LPI (LP Information) latest study, the global Clozapine market size was valued at US$ 341.4 million in 2023. With growing demand in downstream market, the Clozapine is forecast to a readjusted size of US$ 463.4 million by 2030 with a CAGR of 4.5% during review period. The research report highlights the growth potential of the global Clozapine market. Clozapine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and s......
  • Global Trazodone Hydrochloride (API) Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 92
    According to our LPI (LP Information) latest study, the global Trazodone Hydrochloride (API) market size was valued at US$ million in 2023. With growing demand in downstream market, the Trazodone Hydrochloride (API) is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Trazodone Hydrochloride (API) market. Trazodone Hydrochloride (API) are expected to show stable growth in the future......
  • Global Trazodone Hydrochloride (API) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 93
    According to our (Global Info Research) latest study, the global Trazodone Hydrochloride (API) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Trazodone, a phenylpiperazine-triazolopyridine antidepressant, was originally discovered and developed in Italy in the 1970s by Angelini research laboratories. Trazodone is used to treat depression and to treat the combination of symptoms of anxiety an......
  • Global Divalproex Sodium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 91
    According to our (Global Info Research) latest study, the global Divalproex Sodium market size was valued at USD 2251.9 million in 2023 and is forecast to a readjusted size of USD 3371.1 million by 2030 with a CAGR of 5.9% during review period. Divalproex Sodium is used to treat certain types of seizures (epilepsy). This medicine is an anticonvulsant that works in the brain tissue to stop seizures. Divalproex Sodium is also used to treat the manic phase of bipolar disorder (manic-d......
  • Global Risperidone Market Research Report 2023
    Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 93
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Risperidone market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Janssen (Johnson & Johnson) - Ajanta Pharma - Amneal Pharmaceuticals - Aurobindo Pharma - Hikma - Sandoz - Lannett - Tris Pharma - Ap......
  • Global Schizophrenia Therapeutics Market Status and Outlook 2023-2028
    Published: 27-Dec-2023        Price: US 3160 Onwards        Pages: 101
    Schizophrenia is usually treated with an individually tailored combination of talking therapy and medicine. Most people with schizophrenia are treated by community mental health teams (CMHTs). The goal of the CMHT is to provide day-to-day support and treatment while ensuring you have as much independence as possible. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market va......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs